{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:11:58Z","timestamp":1781071918972,"version":"3.54.1"},"reference-count":191,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Opioids are substances derived from opium (natural opioids). In its raw state, opium is a gummy latex extracted from Papaver somniferum. The use of opioids and their negative health consequences among people who use drugs have been studied. Today, opioids are still the most commonly used and effective analgesic treatments for severe pain, but their use and abuse causes detrimental side effects for health, including addiction, thus impacting the user\u2019s quality of life and causing overdose. The mesocorticolimbic dopaminergic circuitry represents the brain circuit mediating both natural rewards and the rewarding aspects of nearly all drugs of abuse, including opioids. Hence, understanding how opioids affect the function of dopaminergic circuitry may be useful for better knowledge of the process and to develop effective therapeutic strategies in addiction. The aim of this review was to summarize the main features of opioids and opioid receptors and focus on the molecular and upcoming epigenetic mechanisms leading to opioid addiction. Since synthetic opioids can be effective for pain management, their ability to induce addiction in athletes, with the risk of incurring doping, is also discussed.<\/jats:p>","DOI":"10.3390\/ijms24097831","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T02:30:52Z","timestamp":1682476252000},"page":"7831","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Molecular and Epigenetic Aspects of Opioid Receptors in Drug Addiction and Pain Management in Sport"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5217-4710","authenticated-orcid":false,"given":"Filomena","family":"Mazzeo","sequence":"first","affiliation":[{"name":"Department of Economics, Law, Cybersecurity and Sports Sciences, University of Naples \u201cParthenope\u201d, 80133 Naples, Italy"},{"name":"Department of Movement Sciences and Wellbeing, University of Naples \u201cParthenope\u201d, 80133 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2174-1118","authenticated-orcid":false,"given":"Rosaria","family":"Meccariello","sequence":"additional","affiliation":[{"name":"Department of Movement Sciences and Wellbeing, University of Naples \u201cParthenope\u201d, 80133 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6338-1793","authenticated-orcid":false,"given":"Ezia","family":"Guatteo","sequence":"additional","affiliation":[{"name":"Department of Movement Sciences and Wellbeing, University of Naples \u201cParthenope\u201d, 80133 Naples, Italy"},{"name":"IRCCS Santa Lucia Foundation, Via del Fosso di Fiorano 64, 00143 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-neuro-080317-061522","article-title":"Endogenous and Exogenous Opioids in Pain","volume":"41","author":"Corder","year":"2018","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bph.12618","article-title":"The role of \u03b4-opioid receptors in learning and memory underlying the development of addiction","volume":"172","author":"Klenowski","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)80235-1","article-title":"CORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization","volume":"341","author":"Mollereau","year":"1994","journal-title":"FEBS Lett."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.6120570","article-title":"Dynorphin is a specific endogenous ligand of the kappa opioid receptor","volume":"215","author":"Chavkin","year":"1982","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(82)90008-5","article-title":"Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors","volume":"77","author":"Oka","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1073\/pnas.76.12.6666","article-title":"Dynorphin-(1-13), an extraordinarily potent opioid peptide","volume":"76","author":"Goldstein","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0006-291X(79)90394-2","article-title":"alpha-Neo-endorphin: A \u201cbig\u201d Leu-enkephalin with potent opiate activity from porcine hypothalami","volume":"86","author":"Kangawa","year":"1979","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2018.09.023","article-title":"Dynorphin\/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders","volume":"1713","author":"Tejeda","year":"2019","journal-title":"Brain Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1200\/EDBK_180469","article-title":"Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives","volume":"37","author":"Bennett","year":"2017","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41401-018-0180-x","article-title":"Drug addiction: A curable mental disorder?","volume":"39","author":"Liu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00213-016-4484-6","article-title":"Antireward, compulsivity, and addiction: Seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction","volume":"234","author":"Koob","year":"2017","journal-title":"Psychopharmacology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biopsych.2019.06.027","article-title":"Epigenetic Mechanisms of Opioid Addiction","volume":"87","author":"Browne","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ije\/dyr184","article-title":"The epigenotype","volume":"41","author":"Waddington","year":"2012","journal-title":"Int. J. Epidemiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-42059-2_1","article-title":"Non-coding RNAs: Classification, Biology and Functioning","volume":"937","author":"Hombach","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"194417","DOI":"10.1016\/j.bbagrm.2019.194417","article-title":"Non-coding RNA regulatory networks","volume":"1863","author":"Panni","year":"2020","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11427-020-1700-9","article-title":"Non-coding RNAs: The new central dogma of cancer biology","volume":"64","author":"Saw","year":"2021","journal-title":"Sci. China Life Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.tibs.2016.05.004","article-title":"Biogenesis and function of transfer RNA-related fragments (tRFs)","volume":"41","author":"Kumar","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_18","first-page":"674","article-title":"Circles reshaping the RNA world: From waste to treasure","volume":"1","author":"Liu","year":"2014","journal-title":"Oncoscience"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"105069","DOI":"10.1016\/j.neuint.2021.105069","article-title":"Epigenetics of addiction","volume":"147","author":"Cadet","year":"2021","journal-title":"Neurochem. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"108215","DOI":"10.1016\/j.pharmthera.2022.108215","article-title":"MicroRNAs in drug addiction: Current status and future perspectives","volume":"236","author":"Zhao","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/ACO.0000000000000613","article-title":"Epigenetics of pain mediators","volume":"31","author":"Odell","year":"2018","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1021\/acschemneuro.1c00841","article-title":"Epigenetic Mechanisms of Neural Plasticity in Chronic Neuropathic Pain","volume":"13","author":"Ghosh","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.trsl.2014.05.012","article-title":"Epigenetic regulation of persistent pain","volume":"165","author":"Bai","year":"2015","journal-title":"Transl. Res."},{"key":"ref_24","first-page":"209","article-title":"Opioid epi-demic spread from Northern and Eastern Europe to Mediterranean Area","volume":"172","author":"Gaudio","year":"2021","journal-title":"Clin. Ter."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcna.2021.08.001","article-title":"What Is Addiction? History, Terminology, and Core Concepts","volume":"106","author":"Olsen","year":"2022","journal-title":"Med. Clin. N. Am."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1165\/rcmb.2008-0488OC","article-title":"Nociceptin modulates bronchoconstriction induced by sensory nerve activation in mouse lung","volume":"42","author":"Orlotti","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2741\/3306","article-title":"The evolution of vertebrate opioid receptors","volume":"14","author":"Stevens","year":"2009","journal-title":"Front. Biosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"15487","DOI":"10.1073\/pnas.0805590105","article-title":"Evolution of vertebrate opioid receptors","volume":"105","author":"Dreborg","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jlcr.3005","article-title":"Positron emission tomography radioligands for the opioid system","volume":"56","author":"Dannals","year":"2013","journal-title":"J. Label. Comp. Radiopharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.lfs.2005.05.036","article-title":"Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients","volume":"77","author":"Stella","year":"2005","journal-title":"Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/mol.112.083279","article-title":"Recent developments in the study of opioid receptors","volume":"83","author":"Cox","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"ref_34","first-page":"171","article-title":"Opiumsvalmuen og morfin gennem tiderne [History of opium poppy and morphine]","volume":"33","author":"Norn","year":"2005","journal-title":"Dan. Med. Arbog."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/pr.114.008979","article-title":"Molecular Pharmacology of \u03b4-Opioid Receptors","volume":"68","author":"Gendron","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/AJP.0b013e31816b2f26","article-title":"Efficacy of opioids for chronic pain: A review of the evidence","volume":"24","author":"Ballantyne","year":"2008","journal-title":"Clin. J. Pain"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.0000000000000839","article-title":"Opioids for chronic noncancer pain: A position paper of the American Academy of Neurology","volume":"83","author":"Franklin","year":"2014","journal-title":"Neurology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"110223","DOI":"10.1016\/j.jclinane.2021.110223","article-title":"Efficacy of systemic lidocaine on postoperative quality of recovery and analgesia after video-assisted thoracic surgery: A randomized controlled trial","volume":"71","author":"Yao","year":"2021","journal-title":"J. Clin. Anesth."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5055\/jom.2012.0114","article-title":"A review of epidural and intrathecal opioids used in the management of postoperative pain","volume":"8","author":"Bujedo","year":"2012","journal-title":"J. Opioid Manag."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/rapm-2018-000023","article-title":"Influence of postoperative analgesia on systemic inflammatory response and postoperative cognitive dysfunction after femoral fractures surgery: A randomized controlled trial","volume":"44","author":"Kristek","year":"2019","journal-title":"Reg. Anesth. Pain Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/y86-001","article-title":"The therapeutic use of heroin: A review of the pharmacological literature","volume":"64","author":"Sawynok","year":"1986","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12079-021-00653-z","article-title":"Opioid receptors signaling network","volume":"16","author":"Gopalakrishnan","year":"2022","journal-title":"J. Cell Commun. Signal."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0736-4679(97)00022-X","article-title":"Midazolam: A review of therapeutic uses and toxicity","volume":"15","author":"Nordt","year":"1997","journal-title":"J. Emerg. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1152\/japplphysiol.00335.2011","article-title":"The \u201cother\u201d respiratory effect of opioids: Suppression of spontaneous augmented (\u201csigh\u201d) breaths","volume":"111","author":"Bell","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpa.2017.02.002","article-title":"Parenteral opioid analgesia: Does it still have a role?","volume":"31","author":"Phillips","year":"2017","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"ref_46","first-page":"287","article-title":"Pain control with intrathecally and peridurally administered opioids and other drugs","volume":"16","author":"Foldes","year":"1991","journal-title":"Anaesthesiol. Reanim."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"108701","DOI":"10.1016\/j.neuropharm.2021.108701","article-title":"Peripheral antinociceptive effects of a bifunctional \u03bc and \u03b4 opioid receptor ligand in rat model of inflammatory bladder pain","volume":"196","author":"Terashvili","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ana.10465","article-title":"Mu opioid receptors and analgesia at the site of a peripheral nerve injury","volume":"53","author":"Truong","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/14659890310001600098","article-title":"Use of naltrexone for the treatment of opiate addiction in campania, italy: The role of family","volume":"8","author":"Loffreda","year":"2003","journal-title":"J. Subst. Use"},{"key":"ref_50","first-page":"91","article-title":"Naltrexone to keep a drug-free condition","volume":"20","author":"Stella","year":"1999","journal-title":"Res. Comm. Alcohol Sub. Abuse"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1074\/jbc.M117.776799","article-title":"Identification of a signaling cascade that maintains constitutive \u03b4-opioid receptor incompetence in peripheral sensory neurons","volume":"26","author":"Brackley","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.celrep.2016.07.084","article-title":"GRK2 Constitutively Governs Peripheral Delta Opioid Receptor Activity","volume":"16","author":"Brackley","year":"2016","journal-title":"Cell Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0950-3528(88)90024-3","article-title":"Action of opiates on gastrointestinal function","volume":"2","author":"Bueno","year":"1988","journal-title":"Baillieres Clin. Gastroenterol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-2999(01)01308-5","article-title":"Opioids in chronic pain","volume":"429","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ajgsup.2014.5","article-title":"Molecular physiology of enteric opioid receptors","volume":"10","author":"Galligan","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_56","first-page":"5","article-title":"Does the kappa opioid receptor system contribute to pain aversion?","volume":"17","author":"Cahill","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2016.06.048","article-title":"The contribution of activated peripheral kappa opioid receptors (kORs) in the inflamed knee joint to anti-nociception","volume":"1648 Pt A","author":"Moon","year":"2016","journal-title":"Brain Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/00000542-199610000-00016","article-title":"Peripheral and spinal actions of opioids in the blockade of the autonomic response evoked by compression of the inflamed knee joint","volume":"85","author":"Nagasaka","year":"1996","journal-title":"Anesthesiology"},{"key":"ref_59","first-page":"492","article-title":"Peptide opioid antagonist separates peripheral and central opioid antitransit effects","volume":"243","author":"Shook","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0024-3205(88)90120-8","article-title":"Orally administered kappa as well as mu opiate agonists delay gastrointestinal transit time in the guinea pig","volume":"42","author":"Kreek","year":"1988","journal-title":"Life Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-0082(99)00067-2","article-title":"Functional changes of the basal ganglia circuitry in Parkinson\u2019s disease","volume":"62","author":"Blandini","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2018.00099","article-title":"A Review of the Pedunculopontine Nucleus in Parkinson\u2019s Disease","volume":"10","author":"French","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1523\/JNEUROSCI.4331-05.2006","article-title":"Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location","volume":"26","author":"Ford","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0959-4388(96)80079-1","article-title":"Neurobiology of addiction","volume":"6","author":"Wise","year":"1996","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","article-title":"Drugs of abuse: Anatomy, pharmacology and function of reward pathways","volume":"13","author":"Koob","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/pr.115.010512","article-title":"Dopamine\u2019s Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders","volume":"67","author":"Arnsten","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41593-018-0152-y","article-title":"What does dopamine mean?","volume":"21","author":"Berke","year":"2018","journal-title":"Nat. Neurosci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2013.03.019","article-title":"Reward and aversion in a heterogeneous midbrain dopamine system","volume":"76 Pt B","author":"Lammel","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.neuron.2015.04.015","article-title":"Role of Dopamine Neurons in Reward and Aversion: A Synaptic Plasticity Perspective","volume":"86","author":"Pignatelli","year":"2015","journal-title":"Neuron"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence","volume":"81","author":"Williams","year":"2001","journal-title":"Physiol. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1098\/rstb.1999.0386","article-title":"Effect of changes in action potential shape on calcium currents and transmitter release in a calyx-type synapse of the rat auditory brainstem","volume":"354","author":"Borst","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrn2148","article-title":"The action potential in mammalian central neurons","volume":"8","author":"Bean","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuroscience.2019.05.009","article-title":"Adolescent Morphine Exposure in Male Rats Alters the Electrophysiological Properties of Locus Coeruleus Neurons of the Male Offspring","volume":"410","author":"Pachenari","year":"2019","journal-title":"Neuroscience"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021317-121615","article-title":"The Evolving Understanding of Dopamine Neurons in the Substantia Nigra and Ventral Tegmental Area","volume":"80","author":"Gantz","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/mds.29269","article-title":"Morpho-Functional Changes of Nigral Dopamine Neurons in an \u03b1-Synuclein Model of Parkinson\u2019s Disease","volume":"38","author":"Ledonne","year":"2023","journal-title":"Mov. Disord."},{"key":"ref_77","first-page":"91","article-title":"Substantia nigra control of basal ganglia nuclei","volume":"73","author":"Guatteo","year":"2009","journal-title":"J. Neural Transm. Suppl."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0166-4328(01)00418-1","article-title":"Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons","volume":"130","author":"Grillner","year":"2002","journal-title":"Behav. Brain Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1152\/jn.1997.77.2.853","article-title":"Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro","volume":"77","author":"Rice","year":"1997","journal-title":"J. Neurophysiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(91)90013-L","article-title":"Stimulus-evoked changes in neostriatal dopamine levels in awake and anesthetized rats as measured by microdialysis","volume":"559","author":"Tepper","year":"1991","journal-title":"Brain Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0006-8993(75)90849-5","article-title":"Dopamine in dendrites of substantia nigra neurons: Suggestions for a role in dendritic terminals","volume":"83","author":"Lindvall","year":"1975","journal-title":"Brain Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/260258a0","article-title":"Release of dopamine from dendrites in rat substantia nigra","volume":"260","author":"Geffen","year":"1976","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.neuron.2004.05.019","article-title":"Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons","volume":"42","author":"Beckstead","year":"2004","journal-title":"Neuron"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0306-4522(95)00326-E","article-title":"G protein-coupled inward rectifier modulated by dopamine agonists in cultured substantia nigra neurons","volume":"69","author":"Kim","year":"1995","journal-title":"Neuroscience"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1113\/jphysiol.1987.sp016787","article-title":"Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta","volume":"392","author":"Lacey","year":"1987","journal-title":"J. Physiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.expneurol.2016.10.009","article-title":"Functional alterations of the dopaminergic and glutamatergic systems in spontaneous \u03b1-synuclein overexpressing rats","volume":"287","author":"Guatteo","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Guatteo, E., Berretta, N., Monda, V., Ledonne, A., and Mercuri, N.B. (2022). Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094508"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ejn.13364","article-title":"On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area","volume":"45","author":"Krashia","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/(SICI)1096-9861(19990419)406:4<503::AID-CNE7>3.0.CO;2-P","article-title":"Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat","volume":"406","author":"Neal","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cne.10154","article-title":"Nociceptin\/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems","volume":"444","author":"Norton","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/164_2018_199","article-title":"NOP Receptor Ligands and Parkinson\u2019s Disease","volume":"254","author":"Mercatelli","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0006-8993(82)90930-1","article-title":"Immunoreactive dynorphin in human brain and pituitary","volume":"233","author":"Gramsch","year":"1982","journal-title":"Brain Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(82)90477-0","article-title":"Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway","volume":"85","author":"Vincent","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-8993(83)91176-9","article-title":"Distribution of immunoreactive dynorphin in the central nervous system of the rat","volume":"280","author":"Zamir","year":"1983","journal-title":"Brain Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0143-4179(85)90053-8","article-title":"Dynorphin-containing pathways in the substantia nigra and ventral tegmentum: A double labeling study using combined immunofluorescence and retrograde tracing","volume":"5","author":"Fallon","year":"1985","journal-title":"Neuropeptides"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/mcne.1994.1039","article-title":"Distribution of kappa opioid receptor mRNA in adult mouse brain: An in situ hybridization histochemistry study","volume":"5","author":"DePaoli","year":"1994","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1073\/pnas.90.21.9954","article-title":"Cloning and pharmacological characterization of a rat kappa opioid receptor","volume":"90","author":"Meng","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_98","first-page":"1015","article-title":"The human delta-opioid receptor: Genomic organization, cDNA cloning, functional expression, and distribution in human brain","volume":"46","author":"Simonin","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.neuropharm.2017.06.019","article-title":"Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor","volume":"123","author":"Margolis","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Corkrum, M., Rothwell, P.E., Thomas, M.J., Kofuji, P., and Araque, A. (2019). Opioid-Mediated Astrocyte-Neuron Signaling in the Nucleus Accumbens. Cells, 8.","DOI":"10.3390\/cells8060586"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/npp.2011.302","article-title":"Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse","volume":"37","author":"Lecca","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1097\/j.pain.0000000000001647","article-title":"The rostromedial tegmental nucleus: A key modulator of pain and opioid analgesia","volume":"160","author":"Taylor","year":"2019","journal-title":"Pain"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"14707","DOI":"10.1523\/JNEUROSCI.2144-14.2014","article-title":"Direct bidirectional \u03bc-opioid control of midbrain dopamine neurons","volume":"34","author":"Margolis","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1113\/jphysiol.1992.sp019136","article-title":"Two types of neurone in the rat ventral tegmental area and their synaptic inputs","volume":"450","author":"Johnson","year":"1992","journal-title":"J. Physiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.neuron.2014.04.030","article-title":"Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal","volume":"82","author":"Matsui","year":"2014","journal-title":"Neuron"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1523\/JNEUROSCI.19-10-03723.1999","article-title":"Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area","volume":"19","author":"Bonci","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e09275","DOI":"10.7554\/eLife.09275","article-title":"Morphine disinhibits glutamatergic input to VTA dopamine neurons and promotes dopamine neuron excitation","volume":"4","author":"Chen","year":"2015","journal-title":"Elife"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.celrep.2017.01.030","article-title":"Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons","volume":"18","author":"Baimel","year":"2017","journal-title":"Cell Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1523\/JNEUROSCI.23-31-09981.2003","article-title":"Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons","volume":"23","author":"Margolis","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1073\/pnas.0511159103","article-title":"Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex","volume":"103","author":"Margolis","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1152\/jn.00963.2006","article-title":"Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents","volume":"97","author":"Ford","year":"2007","journal-title":"J. Neurophysiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-4522(96)00444-7","article-title":"A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids","volume":"77","author":"Cameron","year":"1997","journal-title":"Neuroscience"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"17729","DOI":"10.1523\/JNEUROSCI.4570-11.2011","article-title":"Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons","volume":"31","author":"Matsui","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1523\/JNEUROSCI.2317-18.2019","article-title":"Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry","volume":"39","author":"Popova","year":"2019","journal-title":"J. Neurosci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1523\/JNEUROSCI.4569-08.2008","article-title":"Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption","volume":"28","author":"Margolis","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bjp.0704806","article-title":"Actions of orphanin FQ\/nociceptin on rat ventral tegmental area neurons in vitro","volume":"136","author":"Zheng","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"ENEURO.0376-19.2020","DOI":"10.1523\/ENEURO.0376-19.2020","article-title":"Differential Modulation of Ventral Tegmental Area Circuits by the Nociceptin\/Orphanin FQ System","volume":"7","author":"Driscoll","year":"2020","journal-title":"eNeuro"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Margolis, E.B., Wallace, T.L., Van Orden, L.J., and Martin, W.J. (2020). Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology. PLoS ONE, 15.","DOI":"10.1101\/2020.04.24.059352"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/npr2.12139","article-title":"Buprenorphine is a weak dopamine releaser relative to heroin, but its pretreatment attenuates heroin-evoked dopamine release in rats","volume":"40","author":"Isaacs","year":"2020","journal-title":"Neuropsychopharmacol. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuropharm.2013.08.028","article-title":"15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse","volume":"76 Pt B","author":"Charbogne","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0196-9781(00)00235-7","article-title":"Cellular neurophysiological actions of nociceptin\/orphanin FQ","volume":"21","author":"Moran","year":"2000","journal-title":"Peptides"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.neuroscience.2007.12.015","article-title":"Epigenetic regulation of kappa opioid receptor gene in neuronal differentiation","volume":"151","author":"Park","year":"2008","journal-title":"Neuroscience"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1073\/pnas.1205565109","article-title":"Stress-induced epigenetic regulation of \u03ba-opioid receptor gene involves transcription factor c-Myc","volume":"109","author":"Persaud","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12031-018-1135-x","article-title":"Potential of Extracellular Vesicles in Neurodegenerative Diseases: Diagnostic and Therapeutic Indications","volume":"66","author":"Izadpanah","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.1007\/s12035-018-0912-4","article-title":"Potential Role of Extracellular Vesicles in the Pathophysiology of Drug Addiction","volume":"55","author":"Rao","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6524-3_1","article-title":"MiRNA Biogenesis and Regulation of Diseases: An Overview","volume":"1509","author":"Vishnoi","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e1680","DOI":"10.1002\/wrna.1680","article-title":"Biogenesis, characterization, and functions of mirtrons","volume":"13","author":"Salim","year":"2022","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Braga, E.A., Fridman, M.V., Moscovtsev, A.A., Filippova, E.A., Dmitriev, A.A., and Kushlinskii, N.E. (2020). LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228855"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.gpb.2016.12.005","article-title":"Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA","volume":"15","author":"Dykes","year":"2017","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","article-title":"The expanding regulatory mechanisms and cellular functions of circular RNAs","volume":"21","author":"Chen","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: Characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"745066","DOI":"10.3389\/fnmol.2021.745066","article-title":"Long Non-coding RNAs and Circular RNAs: Insights Into Microglia and Astrocyte Mediated Neurological Diseases","volume":"14","author":"Chen","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-981-10-8022-7_49","article-title":"Morphine","volume":"Volume 1","author":"Kong","year":"2018","journal-title":"Natural Small Molecule Drugs from Plants"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"645","DOI":"10.14348\/molcells.2016.0137","article-title":"Brain reward circuits in morphine addiction","volume":"39","author":"Kim","year":"2016","journal-title":"Mol. Cells"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/13880209.2019.1651343","article-title":"Long non-coding RNA MEG3 attends to morphine-mediated autophagy of HT22 cells through modulating ERK pathway","volume":"57","author":"Gao","year":"2019","journal-title":"Pharm. Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: From microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fimmu.2020.00421","article-title":"\u03b4-Opioid Receptors, microRNAs, and Neuroinflammation in Cerebral Ischemia\/Hypoxia","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/1871524922666220929153215","article-title":"Neuroinflammation: Molecular Mechanisms And Therapeutic Perspectives","volume":"22","author":"Marino","year":"2022","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00018-015-2067-z","article-title":"Effects of addictive drugs on adult neural stem\/progenitor cells","volume":"73","author":"Xu","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/stem.3334","article-title":"Kappa opioid receptor controls neural stem cell differentiation via a miR-7a\/Pax6 dependent pathway","volume":"39","author":"Xu","year":"2021","journal-title":"Stem Cells"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/stem.1774","article-title":"Morphine modulates mouse hippocampal progenitor cell lineages by upregulating miR-181a level","volume":"32","author":"Xu","year":"2014","journal-title":"Stem Cells"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e13086","DOI":"10.1111\/adb.13086","article-title":"MicroRNA-132 is involved in morphine dependence via modifying the structural plasticity of the dentate gyrus neurons in rats","volume":"27","author":"Jia","year":"2022","journal-title":"Addict. Biol."},{"key":"ref_143","first-page":"7114","article-title":"Morphine induces the apoptosis of mouse hippocampal neurons HT-22 through upregulating miR-181-5p","volume":"24","author":"Wang","year":"2020","journal-title":"Eur. Rev Med. Pharmacol. Sci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1111\/ejn.15650","article-title":"microRNA expression levels in the nucleus accumbens correlate with morphine-taking but not morphine-seeking behaviour in male rats","volume":"55","author":"Gillespie","year":"2022","journal-title":"Eur. J. Neurosci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"40413","DOI":"10.1038\/srep40413","article-title":"MiR-218 targets MeCP2 and inhibits heroin seeking behavior","volume":"7","author":"Yan","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/mrdd.10026","article-title":"Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype","volume":"8","author":"Hoffbuhr","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s00213-021-05854-3","article-title":"Role of nucleus accumbens microRNA-181a and MeCP2 in incubation of heroin craving in male rats","volume":"238","author":"Xu","year":"2021","journal-title":"Psychopharmacology"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/ijnp\/pyz015","article-title":"Overexpression of miR-9 in the Nucleus Accumbens Increases Oxycodone Self-Administration","volume":"22","author":"Mavrikaki","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Shahjin, F., Guda, R.S., Schaal, V.L., Odegaard, K., Clark, A., Gowen, A., Xiao, P., Lisco, S.J., Pendyala, G., and Yelamanchili, S.V. (2019). Brain-Derived Extracellular Vesicle microRNA Signatures Associated with In Utero and Postnatal Oxycodone Exposure. Cells, 9.","DOI":"10.3390\/cells9010021"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"113685","DOI":"10.1016\/j.biopha.2022.113685","article-title":"Multi-omics study reveals associations among neurotransmitter, extracellular vesicle-derived microRNA and psychiatric comorbidities during heroin and methamphetamine withdrawal","volume":"155","author":"Chen","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Floris, G., Gillespie, A., Zanda, M.T., Dabrowski, K.R., and Sillivan, S.E. (2022). Heroin Regulates Orbitofrontal Circular RNAs. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031453"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"105722","DOI":"10.1016\/j.phrs.2021.105722","article-title":"The role of circTmeff-1 in incubation of context-induced morphine craving","volume":"170","author":"Yu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ijnp\/pyac004","article-title":"Roles of miR-592-3p and Its Target Gene, TMEFF1, in the Nucleus Accumbens During Incubation of Morphine Craving","volume":"25","author":"Xie","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.neubiorev.2012.02.004","article-title":"Reconsolidation of drug memories","volume":"36","author":"Sorg","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainresbull.2022.04.010","article-title":"CircTmeff-1 in the nucleus accumbens regulates the reconsolidation of cocaine-associated memory","volume":"185","author":"Shen","year":"2022","journal-title":"Brain Res. Bull."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"484","DOI":"10.5124\/jkma.2021.64.7.484","article-title":"Treatment of neuropathic pain","volume":"64","author":"Sohn","year":"2021","journal-title":"J. Korean Med. Assoc."},{"key":"ref_157","unstructured":"NIDA (2023, March 25). Prescription Opioids DrugFacts. 1 June 2021, Available online: http:\/\/nida.nih.gov\/publications\/drugfacts\/prescription-opioids."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13722-021-00238-6","article-title":"The NIDA clinical trials network: Evolving, expanding, and addressing the opioid epidemic","volume":"16","author":"Tai","year":"2021","journal-title":"Addict Sci. Clin. Pract."},{"key":"ref_159","first-page":"2","article-title":"Dietary supplements use in competitive and non-competitive boxer: An exploratory study","volume":"8","author":"Mazzeo","year":"2016","journal-title":"Biol. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/14659891.2019.1642410","article-title":"Attitude and practice of substance misuse and dietary supplements to improve performance in sport","volume":"24","author":"Mazzeo","year":"2019","journal-title":"J. Subst. Use"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/bjsports-2017-097867","article-title":"A painful dilemma? Analgesic use in sport and the role of anti-doping","volume":"51","author":"Vernec","year":"2017","journal-title":"Br. J. Sports Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-med-011817-044739","article-title":"Use and Misuse of Opioids in Chronic Pain","volume":"69","author":"Volkow","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/jcph.1276","article-title":"Opioid Therapy in Acute and Chronic Pain","volume":"58","author":"Nafziger","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s13181-018-0685-1","article-title":"Pharmacologic Treatment of Opioid Use Disorder: A Review of Pharmacotherapy, Adjuncts, and Toxicity","volume":"14","author":"Toce","year":"2018","journal-title":"J. Med. Toxicol."},{"key":"ref_165","first-page":"86","article-title":"Musculoskeletal traumatic pain","volume":"37","author":"Antunes","year":"2022","journal-title":"DOLOR"},{"key":"ref_166","first-page":"S806","article-title":"From \u201csliding\u201d to \u201cwinding\u201d filaments theory: A narrative review of mechanisms behind skeletal muscle contraction","volume":"15","author":"Montesano","year":"2020","journal-title":"J. Hum. Sport Exerc."},{"key":"ref_167","first-page":"7","article-title":"Soccer fields in synthetic and natural grass: A comparative study on muscular injuries of the lower limb","volume":"14","author":"Pietro","year":"2020","journal-title":"Sport Sci."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pmrj.2017.07.068","article-title":"Analgesics and sport performance: Beyond the pain-modulating effects","volume":"10","author":"Holgado","year":"2018","journal-title":"PM R"},{"key":"ref_169","first-page":"S970","article-title":"Use and attitudes toward dietary supplements and drugs amongst Italian elite athletes and its correlation with banned doping substances","volume":"14","author":"Mazzeo","year":"2019","journal-title":"J. Hum. Sport Exerc."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF02853167","article-title":"Over-the-counter oral nonsteroidal anti-inflammatory drugs: A pharmacoepidemiologic study in southern Italy","volume":"18","author":"Motola","year":"2001","journal-title":"Adv. Ther."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0014-827X(03)00142-3","article-title":"2-aryl-3-phenylamino-4,5-dihydro-2h-benz[g]indazoles with analgesic activity","volume":"58","author":"Schenone","year":"2003","journal-title":"Farmaco"},{"key":"ref_172","first-page":"705","article-title":"Data investigation on the performance-enhancing drugs spread in Italy among young athletes: Prevention trough education and the fight against doping in sport","volume":"16","author":"Mazzeo","year":"2021","journal-title":"J. Hum. Sport Exerc."},{"key":"ref_173","first-page":"2378","article-title":"Updated evidence report for the anti-doping research: Analysis from 2008 to 2018 for performance-enhancing drugs and gene doping test development","volume":"20","author":"Mazzeo","year":"2020","journal-title":"J. Phys. Ed. Sport"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/1941738120933542","article-title":"Opioid Use in Athletes: A Systematic Review","volume":"12","author":"Ekhtiari","year":"2020","journal-title":"Sports Health"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"113","DOI":"10.26773\/smj.181020","article-title":"Anabolic steroid use in sports and in physical activity: Overview and analysis","volume":"16","author":"Mazzeo","year":"2018","journal-title":"Sport Mont."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/0974-8369.1000263","article-title":"Doping in Italy: An analysis of its spread in ten years","volume":"8","author":"Mazzeo","year":"2016","journal-title":"Biol. Med."},{"key":"ref_177","unstructured":"Del Tredici, A. (2021). Optimizing Opioid Therapy with Pharmacogenetics. Pract. Pain Manag., 21, Available online: https:\/\/www.practicalpainmanagement.com\/treatments\/pharmacological\/opioids\/optimizing-opioid-therapy-pharmacogenetics."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"237","DOI":"10.36076\/ppj.2008\/11\/237","article-title":"Variations in opioid responsiveness","volume":"11","author":"Smith","year":"2008","journal-title":"Pain Physician"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/phar.1986","article-title":"Review of Opioid Pharmacogenetics and Considerations for Pain Management","volume":"37","author":"Hamadeh","year":"2017","journal-title":"Pharmacotherapy"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cpt.2149","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy","volume":"110","author":"Crews","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_181","first-page":"97","article-title":"From gene doping to athlete biological passport","volume":"9","author":"Mazzeo","year":"2016","journal-title":"Sport Sci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1177\/0269881120944162","article-title":"The pharmacogenetics of opioid treatment for pain management","volume":"34","author":"Singh","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"ref_183","first-page":"18","article-title":"New technology and no drugs in sport: Gene doping regulation, education and research","volume":"14","author":"Mazzeo","year":"2020","journal-title":"Sport Sci."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"113478","DOI":"10.1016\/j.bbr.2021.113478","article-title":"Differential expression of H19, BC1, MIAT1, and MALAT1 long non-coding RNAs within key brain reward regions after repeated morphine treatment","volume":"414","author":"Ahmadi","year":"2021","journal-title":"Behav. Brain Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbi.2022.09.018","article-title":"CircNf1-mediated CXCL12 expression in the spinal cord contributes to morphine analgesic tolerance","volume":"107","author":"Bai","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e2016409118","DOI":"10.1073\/pnas.2016409118","article-title":"CXCR4\/CXCL12-mediated entrapment of axons at the injury site compromises optic nerve regeneration","volume":"118","author":"Hilla","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pneurobio.2007.11.003","article-title":"Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology","volume":"84","author":"Li","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/dta.294","article-title":"Impact of physical activity and doping on epigenetic gene regulation","volume":"3","author":"Schwarzenbach","year":"2011","journal-title":"Drug Test. Anal."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/2211536611666220422123437","article-title":"Circulating MicroRNAs as a New Class of Biomarkers of Physiological Reactions of the Organism to the Intake of Dietary Supplements and Drugs","volume":"11","author":"Postnikov","year":"2022","journal-title":"Microrna"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2217\/pgs-2017-0040","article-title":"Pharmacoepigenomics of opiates and methadone maintenance treatment: Current data and perspectives","volume":"18","author":"Jourdaine","year":"2017","journal-title":"Pharmacogenomics"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"661781","DOI":"10.3389\/fphar.2021.661781","article-title":"Codeine and Tramadol Use in Athletes: A Potential for Abuse","volume":"12","author":"Zandonai","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/9\/7831\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:23:09Z","timestamp":1760124189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/9\/7831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":191,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["ijms24097831"],"URL":"https:\/\/doi.org\/10.3390\/ijms24097831","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]}}}